Skip to content
Search

Latest Stories

Pharmacy technicians can supply medicines under PGDs from end of this month

Pharmacy technicians can supply medicines under PGDs from end of this month

There will be no immediate change in the provision of community pharmacy services

New amendments to the Human Medicines Regulations will soon allow registered pharmacy technicians to supply and administer medicines under Patient Group Directions (PGDs).

Laid before Parliament at the end of May, the legislative changes will come into effect from June 26, 2024, the Community Pharmacy England (CPE) announced today.


The introduction of this new legislation follows an announcement made by the Department of Health and Social Care (DHSC) earlier this year.

The regulatory adjustments provide the legal framework for pharmacy technicians to engage in the supply and administration of medicines under PGDs in the course of their professional practice. However, there will be no immediate change in the provision of community pharmacy services, the CPE noted

“Any updates to services first need to be considered in negotiations and, where agreed, the relevant service directions and specifications would then be amended,” it added.

Gordon Hockey, Community Pharmacy England's Director of Legal Affairs, commented, “As the clinical skills of community pharmacists are put to greater use through services such as Pharmacy First, it is important to ensure that pharmacies can make best use of skill mix across the whole team.”

The DHSC conducted a consultation on the use of PGDs by pharmacy technicians last year, which the Committee responded to positively.

CPE noted that this development, coupled with proposed legislative changes in the Supervision Consultation (the outcome of which is still pending), will enable pharmacy technicians to fully utilise their skills and knowledge.

Malcolm Harrison, CEO of the Company Chemists’ Association (CCA), highlighted that this move is significant in adapting the workforce to meet future needs.

“The CCA has long campaigned in favour of pharmacy technicians being allowed to supply and administer medicines using Patient Group Directions (PGDs).

“We are delighted this change has come through which will further harness the skills of registered pharmacy technicians, who already play an integral role in community pharmacy. This is an important step in changing the workforce to reflect the needs of the future and offers a route to increasing vital future clinical capacity.

Empowering the workforce to move into the future and meet patient needs is a great first step,” he said.

He further urged NHS England to commission services ambitiously, along with providing additional funding, so that the sector can benefit from this change.

More For You

Mike Hewitson, superintendent pharmacist & managing director of Beaminster Pharmacy

Mike Hewitson elected as NPA board member for England

Mike Hewitson elected as NPA board member for England: New term begins April

Mike Hewitson, superintendent pharmacist & managing director ofBeaminster Pharmacy, has been elected as the next National Pharmacy Association (NPA) board member for England.

Since 2023, Hewitson has served as chair of Community Pharmacy Dorset. He is also a member of Somerset Council and a Non-Executive Director at HubRx.

Keep ReadingShow less
Store closures 2024: Chemists among hardest hit

Over 600 chemist shops belonging to multiples and chains were closed last year

Getty Images

35 shops closed per day last year, chemists worst affected

More shops are expected to exit the UK high streets driven by driven by rising operational costs and a continued shift towards online shopping and transactions.

According to figures from PwC, a total of 12,804 outlets operated by chains (those with five or more locations) exited high streets, shopping centres and retail parks in 2024 – equivalent to 35 closures per day.

Keep ReadingShow less
Empty pharmacy shelves due to UK medicine shortages.

The government has said it's investing up to £520m to manufacture more medicines

Pic credit: iStock

Brexit blamed for UK medicine shortages with "little sign of recovery"

The UK is facing “a worsening situation” with drugs shortages compared to the rest of Europe as a result of Brexit, according to the Nuffield Trust health thinktank.

It comes of the back of data that revealed that the department of health and social care (DHSC) received 1,938 notifications of disruptions to medicine supply last year – the highest in four years.

Keep ReadingShow less
Alert! Patients on Promixin should be switched to alternatives by 30 April

Promixin is licensed for treating chronic pulmonary infections caused by Pseudomonas aeruginosa in adults and children with cystic fibrosis

Getty Images

Medicine shortage: Promixin to be discontinued from May 2025

The Department of Health and Social Care (DHSC) and NHS England have issued a national patient safety alert regarding the upcoming shortage of Promixin (colistimethate).

The alert, issued on 17 March 2025, states that Promixin (colistimethate) 1-million-unit powder for nebuliser solution unit dose vials (UDVs) will be discontinued from early May 2025, with stocks expected to be exhausted by this time.

Keep ReadingShow less
PAGB welcomes new vice-presidents and treasurer to Board

Rob Elliott and Bas Vorsteveld ( L-R)

Bas Vorsteveld will now oversee the Kenvue’s business in Northern Europe

PAGB appoints new vice-presidents and treasurer to Board

PAGB, the consumer healthcare association, has announced the appointment of two new vice-presidents and a treasurer to their Board.

Bas Vorsteveld, area managing director for Northern Europe at Kenvue, and Rob Elliott, OTC centre of excellence lead at Viatris, have been elected as vice-presidents.

Keep ReadingShow less